Mehendale H M
Drug Metab Dispos. 1976 Mar-Apr;4(2):124-32.
The hepatic disposition of four chlorinated biphenyls was studied in isolated perfused rat liver preparations perfused with 30% rat blood. Biliary excretion of 14C-labeled 4-chlorobiphenyl (1-CB): 4,4'-dichlorobiphenyl (2-CB): 2,4,5,2',5'-pentachlorobiphenyl (5-CB) and 2,4,5,2',5'-hexachlorobiphenyl (6-CB) appeared to be inversely related to increased chlorination. Each of the compounds was rapidly taken up by the liver from the circulating perfusate. After 4 hr of perfusion, biliary excretion of 14C from 1-CB, 2-CB, 5-CB, and 6-CB was 48.2, 29.6, 20.5, and 1.3% of total dose, respectively. For 1-CB, this rate of biliary elimination represents a maximum perfusate/bile ratio of 107. About 97% of the label in the bile from 1-CB experiments was in the form of metabolites. Biliary excretion of 1-CB was biphasic: an initial rapid phase (t 1/2 = 13 min) was followed by a slower second phase (t 1/2 = 122 min). When the metabolites of 1-CB were added to the perfusate, biliary excretion of these metabolites was monophasic; t 1/2 = 120 min, which corresponded to the slower phase observed when the parent compound was presented to the liver. 1-CB disappeared from the perfusate via a biphasic process. Metabolites of 1-CB effused into the perfusate immediately after the initial rapid uptake of 1-CB by the liver, and the recirculating pool of metabolites was eliminated in the bile by the slow postsynthetic phase of biliary elimination. Less than 2% of 1-CB was present as the parent compound in the perfusion system after 4 hr of perfusion. These findings indicate that the metabolism of 1-CB is not the limiting factor in the hepatic disposition of 1-CB and that the circulating metabolites of 1-CB effusing from the liver might be the major source for urinary excretion.
在使用30%大鼠血液灌注的离体灌注大鼠肝脏制剂中,研究了四种氯代联苯的肝脏处置情况。14C标记的4-氯联苯(1-CB)、4,4'-二氯联苯(2-CB)、2,4,5,2',5'-五氯联苯(5-CB)和2,4,5,2',5'-六氯联苯(6-CB)的胆汁排泄似乎与氯化程度的增加呈负相关。每种化合物都能迅速从循环灌注液中被肝脏摄取。灌注4小时后,1-CB、2-CB、5-CB和6-CB的14C胆汁排泄量分别占总剂量的48.2%、29.6%、20.5%和1.3%。对于1-CB,这种胆汁消除率代表最大灌注液/胆汁比为107。1-CB实验中胆汁中约97%的标记物以代谢物的形式存在。1-CB的胆汁排泄是双相的:初始快速相(t1/2 = 13分钟)之后是较慢的第二相(t1/2 = 122分钟)。当将1-CB的代谢物添加到灌注液中时,这些代谢物的胆汁排泄是单相的;t1/2 = 120分钟,这与向肝脏给予母体化合物时观察到的较慢相相对应。1-CB通过双相过程从灌注液中消失。1-CB被肝脏初始快速摄取后,其代谢物立即进入灌注液,并且代谢物的再循环池通过胆汁消除的缓慢合成后阶段在胆汁中被清除。灌注4小时后,灌注系统中以母体化合物形式存在的1-CB不到2%。这些发现表明,1-CB的代谢不是1-CB肝脏处置的限制因素,并且从肝脏中流出的1-CB循环代谢物可能是尿液排泄的主要来源。